China SDIC Gaoxin Industrial Investment
High-Tech Building No. 1 South Binhe Road, Xicheng District, Beijing, China
Overview
China SDIC Gaoxin is a venture capital firm specializing in the investment, acquisition and merger of early stage and fast-growth stage enterprise. The firm typically invests in small to medium size companies. It prefers to invest in high-tech industrial investment such as new material, medical, software system integration, precision mechanism component, bioengineering, environment protection, information technology, medical field, biology, telecommunications technology, new pharmaceutical, biological engineering, resource utilization, new model and advanced manufacturing, and new energy. The firm also invests in traditional areas, including international trade, logistics, investment consultation, information network, and other relevant trade and service. China Gaoxin Investment Group Corp. was founded in 1987 and is based in Beijing, China.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Asset Management
- Financial Services
- Venture Capital
Investment portfolio
- Peijia Medical
Participated · Series C · Nov 2019
Peijia Medical is a Chinese medical instrument provider. The company raised 700 million yuan ($100 million) in a Series C round. Investors in the round include Matrix Partners China, Lilly Asia Ventures, Grand Flight, China SDIC Gaoxin Industrial Investment Corp, and China Chengtong Holdings Group. The raise was disclosed in a company filing. No operating metrics or details on the use of proceeds were disclosed in the article.
Team
No current team members are available.